Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present CryoPort, Inc. (NASDAQ: CYRX).

Full DD Report for CYRX

You must become a subscriber to view this report.


Recent News from (NASDAQ: CYRX)

CryoPort: What Do Earnings Tell Us?
It’s the work on your desk. Do well with what you already have and more will come. - Charlie Munger Despite the recent share price depreciation, CryoPort (NASDAQ: CYRX ) is still one of the strong performers for Integrated BioSci Investing. Since our recommendation , the stock pr...
Source: SeekingAlpha
Date: August, 23 2018 22:55
Cryoport Inc. (CYRX) CEO Jerrell Shelton on Q2 2018 Results - Earnings Call Transcript
Cryoport Inc. (CYRX) Q2 2018 Earnings Conference Call August 9, 2018 16:30 PM ET Executives Todd Fromer - KCSA Strategic Communications Jerrell Shelton - President and Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Commercial Officer ...
Source: SeekingAlpha
Date: August, 13 2018 02:13
Cryoport Inc 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Cryoport Inc in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 11 2018 00:36
CryoPort misses by $0.02, beats on revenue
CryoPort (NASDAQ: CYRX ): Q2 EPS of -$0.09 misses by $0.02 . More news on: Cryoport Inc, Earnings news and commentary, Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: August, 09 2018 16:35
Cryoport Revenue Grows 59% for Second Quarter 2018; 73% in Biopharma
IRVINE, Calif. , Aug. 9, 2018 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced financial results for the three and six-mon...
Source: PR Newswire
Date: August, 09 2018 16:10
Cryoport Launches CryoStork? Insurance to Support IVF Logistics Solutions
IRVINE, Calif. , Aug. 7, 2018 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced the upcoming launch of CryoStork℠ Insurance, which is designed ...
Source: PR Newswire
Date: August, 07 2018 08:30
Medical Stock Investing: 2018 Update
Given that we are just past the midpoint, I thought it would be a good time to review and update my 2018 forecast and stock picks. As I suggested, 2018 has turned out to be a stockpicker's year. The fundamentals of the US healthcare industry remain strong, as demographics, chronic disease prev...
Source: SeekingAlpha
Date: August, 02 2018 09:37
Cryoport to Report Second Quarter 2018 Financial Results on August 9th, 2018
IRVINE, Calif. , Aug. 1, 2018 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or "the Company"), the world's leading temperature controlled logistics company dedicated to the life sciences industry, today announced that the Company will report financial resu...
Source: PR Newswire
Date: August, 01 2018 08:30
Cryoport: Elucidating The Latest Developments Centering A CAR-T Servicer
I am a biography nut myself. And I think when you're trying to teach the great concept that works, it helps to tie them to the lives and personalities of the people who developed them. I think you learn economics better if you make Adam Smith your friend. That sounds funny, making friends amo...
Source: SeekingAlpha
Date: July, 29 2018 05:46
Cryoport Partners with World Courier to Provide Best-In-Class Logistics Platform for Global Cell and Gene Therapy Market
IRVINE, Calif. , July 16, 2018 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), today announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport's full suite of temperature-controlled solutions into its global network.  This integrated platfor...
Source: PR Newswire
Date: July, 16 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1011.1910.7511.1910.31165,078
2018-12-0711.2411.3011.6410.96111,051
2018-12-0610.8411.1611.177710.8484,075
2018-12-0511.1210.9911.2910.6175166,249
2018-12-0411.1210.9511.2910.6175126,858

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1036,34260,58759.9832Short
2018-12-0721,52644,29948.5925Short
2018-12-0615,75532,12949.0367Short
2018-12-0421,88733,67964.9871Short
2018-12-035,51323,72223.2400Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CYRX.


About CryoPort, Inc. (NASDAQ: CYRX)

Logo for CryoPort, Inc. (NASDAQ: CYRX)

Cryoport provides leading edge cryogenic logistics solutions to the life sciences industry through the combination of purpose built proprietary packaging, advanced information technology and highly skilled logistics expertise which manages the entire cold chain logistics process. Cryoport Express liquid nitrogen dry vapor shippers are validated to maintain a constant C temperature for a plus day dynamic shipment duration, and its Cryoportal Logistics Management Platform assists in managing the entire logistics process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport s total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a green and environmentally friendly solution. Cryoport service options include recording the chain of condition and chain of custody for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information visit www.cryoport.com.

 

 

 

Current Management

  • Jerrell Shelton / CEO, President
  • Robert A. Stefanovich / CFO
  • Steven Leatherman / CCO
  • Mary Tibbs / Controller
  • Richard G. Rathmann / Chairman
  • Richard J. Burman /
  • Ramkumar Mandalam /
  • Jerrell Shelton /
  • Edward J. Zecchini /

Current Share Structure

  • Market Cap: $266,555,357 - 05/15/2018
  • Authorized: 20,833,333 - 03/31/2015
  • Issue and Outstanding: 27,679,684 - 04/30/2018

 


Recent Filings from (NASDAQ: CYRX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 03 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: March, 30 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 08 2018
Amendment to a previously filed SC TO-I
Filing Type: SC TO-I/AFiling Source: edgar
Filing Date: February, 08 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: February, 01 2018
Amendment to a previously filed SC TO-I
Filing Type: SC TO-I/AFiling Source: edgar
Filing Date: January, 22 2018

 

 


Daily Technical Chart for (NASDAQ: CYRX)

Daily Technical Chart for (NASDAQ: CYRX)


Stay tuned for daily updates and more on (NASDAQ: CYRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CYRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CYRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CYRX and does not buy, sell, or trade any shares of CYRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/